Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. The company is comprised of two franchises – Pain Management and Chronic Care – that address some of today’s most important healthcare needs, namely reducing the use of opioids while helping patients recover faster and preventing infection.
Avanos sells its recognized brands and products in more than 90 countries and holds leading market positions in multiple categories across its portfolio.
Avanos operates 8 principal medical device production facilities with 4,500 employees worldwide – generating approximately $612 million in net revenue.
Avanos Medical, Inc., is traded on the New York Stock Exchange under the ticker symbol “AVNS”.
Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com.